Literature DB >> 23467568

The association of smoking with venous thrombosis in women. A population-based, case-control study.

M Blondon1, K L Wiggins, B McKnight, B M Psaty, K M Rice, S R Heckbert, N L Smith.   

Abstract

The evidence for an association between smoking and venous thrombosis (VT) is inconsistent, and its mediation pathways remain to be fully elucidated. A population-based, case-control study was conducted in a large, integrated healthcare system in Washington State, USA. Cases were women aged 18-90 years who experienced a validated incident deep-vein thrombosis or pulmonary embolism between January 1, 1995, and December 31, 2009. Controls were randomly selected from members of the healthcare system. Smoking status (current, former, never) was assessed from medical records review and, for a subset, also by telephone interview. Multivariable logistic regression was used to estimate odds ratios (OR) associated with smoking status. We identified 2,278 cases and 5,927 controls. Subjects comprised mostly postmenopausal white women with a mean age of 66 years and a current smoking prevalence of 10%. Compared to never-smokers, current and former smokers were at higher risk of VT (adjusted OR 1.21, 95% confidence interval [CI] 1.02-1.44 and OR 1.15, 95%CI 1.03-1.29, respectively). These associations were attenuated with further adjustment for potential mediators (cardiovascular disease, congestive heart failure, cancer, recent hospitalisations and physical activity): OR 1.02 (95%CI 0.83-1.25) and 0.95 (95%CI 0.83-1.08), respectively. In conclusion, the modestly increased risk of VT in women who are current or former smokers might be explained by the occurrence of smoking-related diseases and decreased physical activity. Our results do not support a direct biological effect of smoking on the risk of VT that is clinically relevant.

Entities:  

Mesh:

Year:  2013        PMID: 23467568      PMCID: PMC4666718          DOI: 10.1160/TH12-10-0732

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

Review 1.  Multiple imputation: a primer.

Authors:  J L Schafer
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

2.  Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.

Authors:  Rajat S Barua; Fridolin Sy; Sundararajan Srikanth; Grace Huang; Usman Javed; Cyrus Buhari; Dennis Margosan; John A Ambrose
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-08       Impact factor: 8.311

3.  Smoking and venous thromboembolism: a Danish follow-up study.

Authors:  M T Severinsen; S R Kristensen; S P Johnsen; C Dethlefsen; A Tjønneland; K Overvad
Journal:  J Thromb Haemost       Date:  2009-06-30       Impact factor: 5.824

4.  Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.

Authors:  Anders G Holst; Gorm Jensen; Eva Prescott
Journal:  Circulation       Date:  2010-04-19       Impact factor: 29.690

5.  Factors influencing the frequency of visits by hypertensive patients to primary care physicians in Winnipeg.

Authors:  N P Roos; K C Carrière; D Friesen
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

6.  Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.

Authors:  Elisabeth R Pomp; Frits R Rosendaal; Carine J M Doggen
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

7.  Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.

Authors:  Susan R Heckbert; Kerri L Wiggins; Nicole L Glazer; Sascha Dublin; Bruce M Psaty; Nicholas L Smith; W T Longstreth; Thomas Lumley
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

8.  Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.

Authors:  Nancy A Rigotti; Andrew L Pipe; Neal L Benowitz; Carmen Arteaga; Dahlia Garza; Serena Tonstad
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

9.  Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men.

Authors:  A Rosengren; M Fredén; P-O Hansson; L Wilhelmsen; H Wedel; H Eriksson
Journal:  J Thromb Haemost       Date:  2007-11-27       Impact factor: 5.824

10.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  13 in total

1.  Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts.

Authors:  Chih-Hsueh Lin; Cheng-Chieh Lin; Wei-Jen Ting; Pei-Ying Pai; Chia-Hua Kuo; Tsung-Jung Ho; Wei-Wen Kuo; Chung-Ho Chang; Chih-Yang Huang; Wan-Teng Lin
Journal:  Age (Dordr)       Date:  2014-08-27

2.  Late failure of a split-thickness skin graft in the setting of homozygous factor V Leiden mutation: a case report and correlative animal model from the Wound Etiology and Healing (WE-HEAL) study.

Authors:  Victoria K Shanmugam; Sean McNish; Joanna Duncan; Brandy Root; Elena Tassi; Anton Wellstein; Bhaskar Kallakury; Christopher E Attinger
Journal:  Int Wound J       Date:  2013-09-13       Impact factor: 3.315

3.  Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort.

Authors:  Brandon Luu; Stephanie Ruderman; Robin Nance; Joseph A C Delaney; Jimmy Ma; Andrew Hahn; Susan R Heckbert; Matthew J Budoff; Kristina Crothers; William C Mathews; Katerina Christopolous; Peter W Hunt; Joseph Eron; Richard Moore; Jeanne Keruly; William B Lober; Greer A Burkholder; Amanda Willig; Geetanjali Chander; Mary E McCaul; Karen Cropsey; Conall O'Cleirigh; Inga Peter; Matthew Feinstein; Judith I Tsui; Sara Lindstroem; Michael Saag; Mari M Kitahata; Heidi M Crane; Lydia N Drumright; Bridget M Whitney
Journal:  HIV Med       Date:  2022-03-28       Impact factor: 3.094

4.  Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.

Authors:  Marc Blondon; Kerri L Wiggins; Astrid Van Hylckama Vlieg; Barbara McKnight; Bruce M Psaty; Kenneth M Rice; Susan R Heckbert; Nicholas L Smith
Journal:  Br J Haematol       Date:  2013-08-08       Impact factor: 6.998

5.  Risk marker associations with venous thrombotic events: a cross-sectional analysis.

Authors:  Beatrice A Golomb; Virginia T Chan; Julie O Denenberg; Sabrina Koperski; Michael H Criqui
Journal:  BMJ Open       Date:  2014-03-21       Impact factor: 2.692

6.  Vaccination Safety: Don't Toss the Champagne With the Cork.

Authors:  Aditya Shah; Douglas W Challener; John C O'Horo; Andrew D Badley
Journal:  Mayo Clin Proc       Date:  2021-07       Impact factor: 7.616

7.  The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture: a retrospective case-control study.

Authors:  Zhixin Ren; Yufei Yuan; Wei Qi; Yanbao Li; Pengcheng Wang
Journal:  J Orthop Surg Res       Date:  2021-07-09       Impact factor: 2.359

Review 8.  Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.

Authors:  Yun-Jiu Cheng; Zhi-Hao Liu; Feng-Juan Yao; Wu-Tao Zeng; Dong-Dan Zheng; Yu-Gang Dong; Su-Hua Wu
Journal:  PLoS Med       Date:  2013-09-17       Impact factor: 11.069

9.  Anti-Apoptotic and Pro-Survival Effect of Alpinate Oxyphyllae Fructus (AOF) in a d-Galactose-Induced Aging Heart.

Authors:  Yung-Ming Chang; Hen-Hong Chang; Wei-Wen Kuo; Hung-Jen Lin; Yu-Lan Yeh; Vijaya Padma Viswanadha; Chin-Chuan Tsai; Ray-Jade Chen; Hsin-Nung Chang; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2016-03-29       Impact factor: 5.923

10.  Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control study.

Authors:  Miao Yu; Ken Ling; Yunfei Teng; Qin Li; Fei Mei; Yiqing Li; Chenxi Ouyang
Journal:  Exp Ther Med       Date:  2016-04-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.